DSM Biologics and Crucell have entered into an agreement with Avid Bioservices to bring Avid into their Vendor Network. Under the terms of the agreement, Avid will be a pre-approved CMO for licensees of the PER.C6 cell line in the western U.S. Avid is the first U.S.-based CMO to be awarded this status. Other terms of the agreement were not disclosed. Karen King, president of DSM Biologics, noted, “We are confident that Avid’s excellent reputation and service level will be instrum...